Registry of Lobbyists
Version 2 of 2 (2006-04-03 to 2006-12-22) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Wyeth Canada
50 Minthorn Blvd Markham, ON L3t 7Y2 Canada |
| Telephone number: | 905-470-3600 Ext.: 3954 |
| Fax number: | 905-470-3861 |
| Responsible officer name and position during the period of this registration: | Arnout Ploos van Amstel, President & Managing Director |
| Description of activities: | Wyeth is one of the world's largest research-based pharmaceutical and health care products comanies. It is a leader in the discovery development, manufacturing and marketing of prescription drugs and over-the-counter medications. It is also a leader in vaccines biotechnology and animal health care. |
| The client is a subsidiary of the following parent companies: |
Wyeth
Five Giralda Farms Madison, NJ United States of America 07940 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: |
Wyeth Canada
1025 Marcel Laurin Blvd. St. Laurent, QC Canada H4R 1J6 Wyeth Pharmaceuticals 50 Minthorn Blvd. Markham, ON Canada L3T 7Y2 |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Craig Martin |
| Position title: | VP, Corporate & Government Affairs |
| Public offices held: | No |
| Name: | Noelle-Dominique Willems |
| Position title: | Director, Federal Affairs |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, International Relations | ||||||
| Subject Matter: Retrospective: | Internet Pharmacy,Cross-border trade,Industry policy re-pharmaceuticals | ||||||
| Subject Matter: Prospective: | Federal patent policy,Internet Pharmacy,Cross-border trade,Industry policy re-pharmaceuticals | ||||||
Details Regarding the Identified Subject Matter
|
|||||||